Showing results (821-830 of 3,701) with videos related to

Sort By:
Pageof 371
International Journal of Clinical Oncology|February 21, 2024
Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021Hidekatsu Nakai, Takahiro Higashi, Tamaki Kakuwa, et al.
International Journal of Clinical Oncology|February 14, 2024
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022Eiki Ichihara, Nobuaki Ochi, Go Makimoto, et al.
International Journal of Clinical Oncology|December 15, 2024
Evaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database studySayuri Nakane, Akinori Yuri, Yuki Miyano, et al.
International Journal of Clinical Oncology|August 8, 2023
Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trialHiroto Kayashima, Shinji Itoh, Mototsugu Shimokawa, et al.
International Journal of Clinical Oncology|April 9, 2026
Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide dataTatsuhiko Shigeto, Yoshihito Yokoyama, Wataru Yamagami, et al.
International Journal of Clinical Oncology|March 26, 2026
Impact of prior PARP inhibitor exposure on the efficacy of platinum-based chemotherapy in platinum-sensitive recurrent ovarian cancer: a propensity score-matched analysisYoshifumi Takahashi, Miku Takadera, Seung Chik Jwa, et al.
International Journal of Clinical Oncology|April 12, 2026
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphomaRisa Nishiyama, Shinichi Makita, Anna Hiratsuka, et al.
International Journal of Clinical Oncology|April 10, 2026
Subsite- and histology-specific epidemiology of head and neck cancers in Japan from 2016 to 2019: an application of a new classification of rare cancersRyoko Rikitake, Yu Mizushima, Yoko Yamamoto, et al.
International Journal of Clinical Oncology|April 9, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational studyHidetaka Nomura, Akiko Abe, Atsushi Fusegi, et al.
International Journal of Clinical Oncology|March 20, 2026
Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018)Hideki Tokunaga, Yusuke Shibuya, Wataru Yamagami, et al.
Pageof 371